跳至主要内容
临床试验/NCT04386018
NCT04386018招募中不适用

A Registered Cohort Study on Natural Course and Drug Efficacy of Inflammatory Demyelination Disease

Ning Wang, MD., PhD.1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2020年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
400
试验地点
1
主要终点
The correlation between clinical phenotypes and Serum antibodies

研究概览

简要总结

This study will provide further insights into the natural course of Inflammatory demyelination disease including clinical features,progression, related antibody spectrum and drug treatment effect

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Outpatient or inpatient
  • Meet the diagnostic criteria of Inflammatory Demyelination Disease.
  • Voluntary participation and informed consent signed by the applicant or his/her family.

排除标准

  • Severe complications
  • Poor prognosis (<1 year survival)
  • Severe mental disorder and inability to cooperate with the examination.

结局指标

主要结局

The correlation between clinical phenotypes and Serum antibodies

时间窗: from date of enrollment until the date of death from any cause,assessed up to 20 years

Different clinical subtypes of Demyelinating Autoimmune Diseases have different course and prognosis.It may be related to different serum antibodies.

次要结局

未报告次要终点

研究者

发起方
Ning Wang, MD., PhD.
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ning Wang, MD., PhD.

Director

First Affiliated Hospital of Fujian Medical University

研究点 (1)

Loading locations...

相似试验